Search Legislation

Health and Care Act 2022

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening OptionsExpand opening options

Status:

This is the original version (as it was originally enacted).

National Health Service Act 2006

This section has no associated Explanatory Notes

138In Schedule 12A (pharmaceutical remuneration), in paragraph 2—

(a)in the heading for “clinical commissioning groups” substitute “integrated care boards”;

(b)in sub-paragraph (3), for “clinical commissioning group” substitute “integrated care board”;

(c)in sub-paragraph (4), for “clinical commissioning groups” substitute “integrated care boards”;

(d)in sub-paragraph (5), for “clinical commissioning group” substitute “integrated care board”;

(e)in sub-paragraph (6)—

(i)for “a clinical commissioning group” substitute “an integrated care board”;

(ii)in paragraphs (a) and (b), for “the group”, in both places it occurs, substitute “the board”;

(f)in sub-paragraph (8), for “a clinical commissioning group” substitute “an integrated care board”;

(g)for sub-paragraph (9) substitute—

(9)For the purposes of sections 223GC and 223M(1)(b) and paragraph 22 of Schedule 1B, any amount of which an integrated care board is notified under sub-paragraph (6) is to be treated as expenditure of the group which is attributable to the performance by it of its functions in the year in question.

Back to top

Options/Help